Category : Orthopedic Oncology / Orthopaedics
In a breakthrough poised to reshape cancer treatment, Houston Methodist has developed the first personalized mRNA cancer vaccine designed to prevent recurrence of osteosarcoma, a rare and aggressive type of bone cancer.
Source : Medical Xpress
On : 19-Jun-2026